Online first

Viral hepatitis C in Poland in the Silesian Province between 2005–2014

Kamil Barański 1  ,  
Department of Epidemiology, School of Medicine, SUM Katowice, Poland
State Provincial Sanitary Inspector, Katowice, Poland
Introduction and objective:
Viral hepatitis C remains one of the major health and social problems related to infectious diseases in Poland. The aim of the study was assessment of the registered changes in the incidence of HCV in the Silesian Province of western Poland during the last 10 years, including age, gender and place of residence.

Material and Methods:
A retrospective analysis was performed of the HCV incidence between 2005–2014 in the Silesian Province. The crude and standardized incidence rates were calculated for males and females in each year. Subsequently, the territorial diversity of the epidemiological situation in the districts was assessed by calculating the average incidence rate over the entire study period.

Incidence rates calculated according to the case definition of 2005 ranged between 5.95/100000 in 2005 to 10.36/100000 in 2014. Analysis of the structure of the incidence showed that during the analyzed period, the majority of hepatitis C cases were related to males (52.5%) rather than females (47.5%), and hepatitis C was more prevalent in younger males (aged 20–49) and older females (aged over 50). After excluding the effect of age, the standardized rates were twice as low, compared to the crude incidence rates.

An increase in the HCV incidence rate was observed in males and females. It is obvious that the detection of additional cases will entail the need to provide funding for the treatment of more patients, which should be included in the map of regional health needs in the coming years. Our study demonstrates the temporal and spatial variability of HCV incidence in the Silesian Province of Poland. The observed increase in the crude and standardized rates suggests that the current registry system of HCV in Poland is more effective now. The current situation is comparable with the data in other EU countries.

Kamil Barański   
Department of Epidemiology, School of Medicine, SUM Katowice, Poland
1. Hepatitis C. System report. The need of changes in the organization of health care system. HTA consulting, Krakow 2014; 8.
2. Warunek W, Janczewska E, Pisula A. Interferon-free 3D therapy in a patient after liver transplantation with the reactivation of infection with genotype 1b HCV. Case Report. Lekarz POZ, 2015; 1(1): 71–74.
3. Krawczyk M, Grąt M, Kornasiewicz O, et all. Results of liver transplantation in The Department of General, Transplant and Liver Surgery at The Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection, Przegl Epidemiol. 2013; 67(1): 5–10.
4. Definitions of cases of infectious diseases for the purposes of epidemiological surveillance, NIPH – NIH Warsaw 2004; 52, http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL1_3.pdf [cited 28.10.2016].
5. Definitions of cases of infectious diseases for the purposes of epidemiological surveillance, NIPH – NIH Warsaw 2011; 62, http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL2_1h.pdf [cited 28.10.2016].
6. Definitions of cases of infectious diseases for the purposes of epidemiological surveillance, NIPH – NIH Warsaw 2014; 58, http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL2_3.pdf [cited 28.10.2016].
7. National Health Programme for 2016–2020. Journal of Laws of 16 th September 2016; (1492), Warsaw 2016; http://www.mz.gov.pl/zdrowie-i-profilaktyka/narodowy-program-zdrowia/npz-2016–2020/cele-operacyjne-npz/ [cited 28.10.2016].
8. Central Statistical Office of Poland, Bank of local data, 2016; https://bdl.stat.gov.pl/BDLS/ [cited 28.10.2016].
9. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray ChJL, Lozano R, InoueM. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series 31, EIP/GPE/EBD. WHO 2001; http://www.who.int/healthinfo/paper31.pdf. [cited 30.05.2016].
10. ESRI: Mapping platform for your institution, 2016; http://www.arcgis.com/about.[cited 03.06.2016].
11. World hepatitis C day 28 th July 2015, NIPH – NIH, Warsaw 2015, http://gis.gov.pl/images/aktualnosci/150728_dzie%C5%84_wzw_sytuacja_epidemiologiczna _hcv_w_polsce.pdf [cited 03.06.2016].
12. Merkinaite S, Lazarus JV, Gore C. Addressing HCV infection in Europe: reported, estimated and undiagnosed cases. Cent Eur J Public Health. 2008; 16 (3): 106–10.
13. Infectious diseases and poisoning in Poland (annual newsletters), Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/inne/Def_PL1_3.pdf. [cited 28.10.2016].
14. Regulation of the Minister of Health of 25 th March 2014 on biological pathogens which are subject to reporting, forms of reports of positive test results of biological pathogens and the circumstances of reporting such cases (Journal of Laws of 2014, item 459, Warsaw, 08.04.2014); http://isap.sejm.gov.pl/DetailsServlet?id=WDU20140000459 [cited 28.10.2016].
15. Kobierski J, Hałdaś M, Władysiuk M. Hepatitis C – the implications and the need for change in the health care system in Poland. J Health Policy Outcomes Res. 2014; 2: 26–34. http://www.jhpor.com/index/artykul/pokaz/hepatitis_c__the_implications_and_the_need_for_change_in_the_health_care_system_in_poland, [cited 28.10.2016].
16. The Act on the Prevention and Combating of Infections and Infectious Human Diseases, (Journal of Laws no 234, item 1570, 30.12.2008), [cited 28.10.2016].
17. Godala M, Szatko F. Reportability of infectious diseases. Part I. The assessment of the awareness of physicians related to reporting infectious diseases to the sanitary inspection. Probl Hig Epidemiol. 2010; 91(2): 198–205.
18. Infectious diseases and poisoning in Poland (2014, annual newsletter), 2014; http://wwwold.pzh.gov.pl/oldpage/epimeld/2014/Ch_2014.pdf. [cited 28.10.2016].
19. Kowalska M, Zejda J.E. Cases of hepatitis C virus (HCV) in the Silesian Province between 1997 and 2002. Przegl Epidemiolog. 2004; 58(3): 435–444.
20. Bruno Pozzetto, Meriam Memmi, Olivier Garraud, Xavier Roblin, and Philippe Berthelot. Health care-associated hepatitis C virus infection, World J Gastroenterol. 2014; 14, 20(46): 17265–17278.
21. Negro F. Epidemiology of hepatitis C in Europe. Digestive and Liver Disease 2014; 46, (1): 58–164, [cited 10.10.2016].
22. Raciborski F, Gujski M, Kłak A, Gierczyński J. HCV in Poland. The strategy to solve the heath problem and actions in the perspective of 2015 and 2016 Report, Institute for Health Protection, Warsaw 2015;16 [cited 28.10.2016].
23. Health and health care in 2014. Central Statistical Office of Poland, Warsaw 2015; 127. http://stat.gov.pl/cps/rde/xbcr/gus/zo_zdrowie_i_ochrona_zdrowia_w_2014.pdf [cited 28.10.2016].
24. Health and health care in 2011, Central Statistical Office of Poland, Warsaw 2012; 175. http://stat.gov.pl/cps/rde/xbcr/gus/zo_zdrowie_i_ochrona_zdrowia_w_2011.pdf [cited 28.10.2016].
25. Stępień M, Rosińska M. Hepatitis c outbreaks in Poland in 2003–2013. Medical procedures as a dominant route of HCV transmission. Przegl Epidemiolog. 2015; 69(3): 465- 472.
26. Healthcare-Associated Hepatitis B and C Outbreaks Reported to the Centers for Disease Control and Prevention (CDC) USA 2008–2015; 1–29. http://www.cdc.gov/hepatitis/outbreaks/pdfs/healthcareinvestigationtable. [cited 10.10.2016].